# Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B

> **NCT00926757** · PHASE4 · COMPLETED · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 80 (actual)

## Conditions studied

- Non Hodgkin's Lymphoma
- Hepatitis B

## Interventions

- **DRUG:** Entecavir prophylaxis
- **DRUG:** Therapeutic entecavir

## Key facts

- **NCT ID:** NCT00926757
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2013-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00926757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00926757, "Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00926757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*